Shelby Kaczmarek
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Anti-BCMA-CAR-IL15 natural killer cells prevent multiple myeloma growth in the bone marrow but allow subsequent emergence of extramedullary disease.
Journal: Cancer letters
Published: July 30, 2025
Entinostat, a histone deacetylase inhibitor, enhances CAR-NK cell anti-tumor activity by sustaining CAR expression.
Journal: Frontiers in immunology
Published: November 22, 2024
Nanoparticle-Mediated mRNA Delivery to Triple-Negative Breast Cancer (TNBC) Patient-Derived Xenograft (PDX) Tumors.
Journal: ACS pharmacology & translational science
Published: October 11, 2024
A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy.
Journal: Journal of extracellular vesicles
Published: March 20, 2023
Simultaneous engineering of natural killer cells for CAR transgenesis and CRISPR-Cas9 knockout using retroviral particles.
Journal: Molecular therapy. Methods & clinical development
Published: September 26, 2022
Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells.
Journal: Cell death & disease
Published: March 14, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026